CD274 and biliary tract cancer: We also discuss CLDN18.2 expression in pancreatic and biliary tract cancers, its relationship with PD-L1, and potential synergy with immunotherapy in gastric cancers, as well as emerging resistance mechanisms and strategies to overcome them.